Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan-Dec:17:2325958218759759.
doi: 10.1177/2325958218759759.

Incidence and Risk Factors for Overweight and Obesity after Initiation of Antiretroviral Therapy in Dar es Salaam, Tanzania

Alexander Kintu  1 , Enju Liu  2 , Ellen Hertzmark  2   3   4 , Donna Spiegelman  2   3   4 , Rachel Margaret Zack  3 , Aisa Muya  5 , David Sando  1   5 , Till Bärnighausen  1 , Wafaie Fawzi  1   2   3
Affiliations

Incidence and Risk Factors for Overweight and Obesity after Initiation of Antiretroviral Therapy in Dar es Salaam, Tanzania

Alexander Kintu et al. J Int Assoc Provid AIDS Care. 2018 Jan-Dec.

Abstract

Objective: To describe the incidence of and risk factors for overweight and obesity following antiretroviral therapy (ART) initiation.

Methods: We used Cox proportional hazards models to investigate risk factors for incident overweight and obesity in 79 074 individuals aged 15 years or older who initiated ART in Dar es Salaam, Tanzania.

Results: Twenty-five percent of the patients became overweight and 10% became obese. The incidence rate of obesity was 3.2 per 100 person-years (95% confidence interval [CI]: 3.1-3.3) in patients who were of normal weight before starting ART and 22.6 per 100 person-years (95% CI: 21.9-23.3) in those who were overweight. Lower CD4 count was associated with a higher risk of overweight and obesity ( P value for trend < .0001).

Conclusion: There is a high burden of overweight and obesity after starting ART, leading to proportions of these 2 conditions that are similar to those in the general population.

Keywords: antiretroviral therapy; incidence; obesity; overweight; risk factors.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Cumulative incidence of overweight (A) and obesity (B) after ART initiation. ART indicates antiretroviral therapy.
See this image and copyright information in PMC

References

    1. Joint United Nations Programme on HIV/AIDS. Global HIV Statistics. 2014. http://www.unaids.org/en/resources/fact-sheet. Accessed February 9, 2018.
    1. The United Republic of Tanzania. Global AIDS Response Country Progress Report. Dar es Salaam, Tanzania: UNAIDS; 2014.
    1. Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science. 2013;339(6122):961–965. doi:10.1126/science.1230413. - PMC - PubMed
    1. WHO. Antiretroviral therapy for HIV infection in adults and adolescents. WHO; http://www.who.int/hiv/pub/arv/adult2010/en/. Accessed February 10, 2018.
    1. Semu H, Zack RM, Liu E, et al. sPrevalence and risk factors for overweight and obesity among HIV-infected adults in Dar es Salaam, Tanzania. J Int Assoc Provid AIDS Care. 2016;15(6):512–521. doi:10.1177/2325957414542574. - PMC - PubMed

Publication types

MeSH terms